Ftse Mib
34.695,94
0,50%
DAX
20.399,16
0,25%
S&P 500
6.087,44
0,87%
NASDAQ
20.028,65
1,73%
Bitcoin
100.928,31
4,40%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Q BioMed Inc (CE) (QBIO) Q BioMed Inc (CE) (QBIO) Notizie

QBIO

Q BioMed (CE) (QBIO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:QBIO
DataOraFonteTitoloSimboloCompagnia
16/06/202322:01Edgar (US Regulatory)Quarterly Report (10-q)USOTC:QBIOQ BioMed Inc (CE)
26/05/202322:56Edgar (US Regulatory)Annual Report (10-k)USOTC:QBIOQ BioMed Inc (CE)
01/03/202319:02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:QBIOQ BioMed Inc (CE)
07/12/202221:01Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:QBIOQ BioMed Inc (CE)
18/11/202223:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:QBIOQ BioMed Inc (CE)
15/07/202223:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:QBIOQ BioMed Inc (CE)
11/01/202222:36Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:QBIOQ BioMed Inc (CE)
26/02/202118:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:QBIOQ BioMed Inc (CE)
11/01/202112:01Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:QBIOQ BioMed Inc (CE)
15/09/202014:53InvestorsHub NewsWireQ BioMed Announces Strontium89 Initial Uptake and Momentum in US and EuropeUSOTC:QBIOQ BioMed Inc (CE)
26/08/202013:30InvestorsHub NewsWireQ BioMed Announces Initiation of GMP Production of Novel COVID-19 Therapeutic for Clinical Trial ProgramUSOTC:QBIOQ BioMed Inc (CE)
11/08/202014:05InvestorsHub NewsWireQ BioMed Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases PainUSOTC:QBIOQ BioMed Inc (CE)
11/06/202018:13Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:QBIOQ BioMed Inc (CE)
21/05/202019:51Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:QBIOQ BioMed Inc (CE)
11/05/202012:00Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:QBIOQ BioMed Inc (CE)
19/03/202021:26Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:QBIOQ BioMed Inc (CE)
16/12/201921:08Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:QBIOQ BioMed Inc (CE)
06/09/201920:16Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:QBIOQ BioMed Inc (CE)
19/03/201916:20InvestorsHub NewsWireGDET CEO Interviewed By Goldman Small Cap Research On New Cannabis BusinessUSOTC:QBIOQ BioMed Inc (CE)
13/12/201821:25Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:QBIOQ BioMed Inc (CE)
06/12/201820:51Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:QBIOQ BioMed Inc (CE)
19/10/201816:47Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:QBIOQ BioMed Inc (CE)
08/06/201817:54Edgar (US Regulatory)Report of Proposed Sale of Securities (144)USOTC:QBIOQ BioMed Inc (CE)
26/02/201821:23Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:QBIOQ BioMed Inc (CE)
04/10/201723:08Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:QBIOQ BioMed Inc (CE)
10/03/201722:10Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:QBIOQ BioMed Inc (CE)
27/07/201615:00InvestorsHub NewsWireFour Trending Stocks Leading Biotech Sector on Heels of Latest R&D and Innovative Drug Therapy AdvancementsUSOTC:QBIOQ BioMed Inc (CE)
30/10/201513:21Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)USOTC:QBIOQ BioMed Inc (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:QBIO

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
ENEL
Enel
BIT
SPM
Saipem
BIT
TIT
Telecom Italia
BIT
BAMI
Banco BPM
BIT
STMMI
ST Microelectronics
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
MONC
Moncler
BIT
BPE
Bper Banca
BIT
CPR
Davide Campari
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
G
Generali
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network